PTC Therapeutics Announces Interim Phase 2 Results
of PTC124 in Cystic Fibrosis
SOUTH PLAINFIELD, NJ - April 4, 2006 - PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, proprietary small-molecule...